At the annual headache symposium of the American Headache Society, Theranica Ltd., a biomedical technology company developing advanced electroceuticals for migraine and other idiopathic pain disorders, will announce the results of TCH-003, a pivotal study of the Nerivio Migra, a novel non-invasive neuromodulation device for the acute treatment of migraine.
November 15, 2018
· 3 min read